over °Ë»ö°á°ú

100 °Ç (1/10 ÂÊ)
»ó¼¼Á¶°Ç    ÆÄÀÏÁ¾·ù 

[ÀÚ±â¼Ò°³¼­] Å©·¡ÇÁÅæ [OVERDARE] Technical Artist ÇÕ°Ý ÀÚ¼Ò¼­

[ÀÚ±â¼Ò°³¼­] Å©·¡ÇÁÅæ [OVERDARE] Technical Artist ÇÕ°Ý ÀÚ¼Ò¼­

[ÀÚ±â¼Ò°³¼­] Å©·¡ÇÁÅæ [OVERDARE] Technical Artist ÇÕ°Ý ÀÚ¼Ò¼­ / [ÀÚ±â¼Ò°³¼­] Å©·¡ÇÁÅæ [OVERDARE] Technical Artist ÇÕ°Ý ÀÚ¼Ò¼­ ¼ºÀå°úÁ¤ ÀúÀÇ ¼ºÀå°úÁ¤Àº Ç×»ó ±â¼ú°ú ¿¹¼ú »çÀÌ¿¡¼­ ¿À°¡´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ¾î¸± ¶§ºÎÅÍ ¹Ì¼ú°ú ÄÄÇ»ÅÍ ÇÁ·Î±×·¡¹Ö¿¡ °ü½ÉÀ» °¡Áö°í ÀÖ¾ú°í, ÀÌ µÎ ºÐ¾ß »çÀÌ¿¡¼­ ÀúÀÇ Ã¢ÀǼºÀ» ¹ßÈÖÇÏ¸ç ¼ºÀåÇß½À´Ï´Ù. ¿¹¼úÀûÀΠǥÇö°ú ±â¼úÀûÀÎ µµ±¸¸¦ °áÇÕÇÏ¿©¡¦
ÀÚ±â¼Ò°³ > ±âŸ   2page   5,000 ¿ø
[À¯±âºÐ±¤È­ÇÐ] NOE - Nuclear Overhauser Enhancement

[À¯±âºÐ±¤È­ÇÐ] NOE - Nuclear Overhauser Enhancement

À¯±âºÐ±¤ ºÐ±¤È­ÇÐ noe overhauser È­ÇÐ / 1.Introduction 2.Decoupling 3.NOE 4.Cross-Polarization 5.Zero & double quantum transition 6.1H-1H NOE 7.Complicated organic molecular structure 8.Complicated display material 9.Proposal - distinguish of stereoisomer 10.Conclusion FileSize : 504K / 1.Introduction 2.Decoupling 3.NOE 4.Cross-Polarization 5.Zero¡¦
·¹Æ÷Æ® > ÀÚ¿¬°úÇÐ   10page   3,200 ¿ø
protain over-expression

protain over-expression

protain over-expression¶ó´Â »ý¹°ÇнÇÇè °á°úº¸°í¼­ÀÔ´Ï´Ù. »ý¹°°á°ú9overexpression-¿¹Áö / Á¥´çÀÇ ³óµµ°¡°¨¼ÒÇϸé ÀÌ¿¡ µû¶ó À¯µµ¹°Áú(Á¥´ç) ºÐÀÚ´Â ¾ïÁ¦¹°Áú·ÎºÎÅÍ ¶³¾îÁø´Ù. Á¥´çºÐÀڷκÎÅÍ ÀÚÀ¯·Î¿öÁü¿¡ µû¶ó ¾ïÁ¦¹°ÁúÀº ¿ø·¡ÀÇ ¸ð¾çÀ¸·Î µÇµ¹¾Æ°¡ ÀÛµ¿À¯ÀüÀÚ¿Í °áÇÕÇÏ°í lac ¿ÀÆä·ÐÀÇ Àü»ç´Â Á¤ÁöµÈ´Ù. ÀÌ¹Ì Á¸ÀçÇß´ø mRNA°¡ ºü¸£°Ô ºÐÇصDZ⠶§¹®¿¡ ±× ÈÄ °ð Çص¶µµ Á¤ÁöµÈ´Ù. ÀÌ¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   3page   1,000 ¿ø
OVERTURE,¸¶ÄÉÆÃ,ºê·£µå,ºê·£µå¸¶ÄÉÆÃ,±â¾÷,¼­ºñ½º¸¶ÄÉÆÃ,±Û·Î¹ú,°æ¿µ,½ÃÀå,»ç·Ê,swot,stp,4p

OVERTURE,¸¶ÄÉÆÃ,ºê·£µå,ºê·£µå¸¶ÄÉÆÃ,±â¾÷,¼­ºñ½º¸¶ÄÉÆÃ,±Û·Î¹ú,°æ¿µ,½ÃÀå,»ç·Ê,swot,stp,4p

OVERTURE,¸¶ÄÉÆÃ,ºê·£µå,ºê·£µå¸¶ÄÉÆÃ,±â¾÷,¼­ºñ½º¸¶ÄÉÆÃ,±Û·Î¹ú,°æ¿µ,½ÃÀå,»ç·Ê,swot,stp,4p / Report Marketing Management Contents ¥°. OVERTURE ±â¾÷¼Ò°³ 1. OVERTURE 2. OVERTURE KOREA 3. OVERTURE ¹Ì±¹º»»ç 4. Á¦ÈÞ³×Æ®¿öÅ© ¥±. OVERTURE ÇöȲ 1. ±¹³»ÀÎÅÍ³Ý ±¤°íÀÇ ¼ºÀå Ãß¼¼ 2. ±¹³» Å°¿öµå °Ë»ö½ÃÀåÀÇ ÇöȲ 3. ±¹³» °æÀïÀÚµéÀÇ ÇöȲ ¥². ¹®Á¦Á¡ 1. ºÎÁ¤Å¬¸¯ 2¡¦
±â¾÷ºÐ¼® > IT°ÔÀÓ   31page   3,000 ¿ø
[»çȸ°úÇÐ] »çȸ±â¹Ý½Ã¼³ - »çȸ°£Á¢ÀÚº»[ SOC ] Social Overhead Capital

[»çȸ°úÇÐ] »çȸ±â¹Ý½Ã¼³ - »çȸ°£Á¢ÀÚº»[ SOC ] Social Overhead Capital

[»çȸ°úÇÐ] »çȸ±â¹Ý½Ã¼³ - »çȸ°£Á¢ÀÚº»[ SOC ] Social Overhead Capital / »çȸ°£Á¢ÀÚº»[ SOC ] Social Overhead Capital Á¤ÀÇ »çȸ°£Á¢ÀÚº»(SOC)À̶õ Á÷Á¢ÀÚº»ÀÌ ¾Æ´Ñ °£Á¢ÀûÀ¸·Î ¿©·¯ °¡Áö »ý»ê È°µ¿¿¡ ±â¿©ÇÏ´Â ÀÚº». Áï »ý»êÈ°µ¿¿¡ Á÷Á¢ÀûÀ¸·Î »ç¿ëµÇÁö´Â ¾ÊÁö¸¸ °æÁ¦È°µ¿À» ¿øÈ°ÇÏ°Ô Çϱâ À§Çؼ­ ²À ÇÊ¿äÇÑ »çȸ±â¹Ý½Ã¼³À» ¸»ÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¿¹·Î µµ·Î, Ç׸¸, öµµµîÀÌ´Ù. Infr¡¦
·¹Æ÷Æ® > Àι®»çȸ   5page   1,500 ¿ø
Colony overexpression

Colony overexpression

ÀçÁ¶ÇÕ DNA¸¦ ¼÷ÁÖ ¼¼Æ÷(´ëÀå±Õ)¿¡ »ðÀÔ(transformation)ÇÏ¿© ±×°ÍÀ» ´Ù·® ¹ßÇöÇÏ´Â ½ÇÇèÀÇ ¸®Æ÷Æ®ÀÔ´Ï´Ù. colonyoverexpression / 3.Methods ¨ç transformationµÈ E coli¸¦ kanamycin(100 ug/ml)ÀÌ Ã·°¡µÈ LB¹èÁö¿¡ Á¢Á¾ ¨è ¼·¾¾ 37µµ¿¡¼­¡¡ cultureÇÏ¿© Èí±¤µµ 600nm¿¡¼­¡¡OD°ªÀÌ 0.6ÀÌ µÇµµ·Ï ¹è¾ç ¨é IPTG¸¦ ³óµµ°¡ 1mMÀÌ µÇµµ·Ï ÷°¡, ¹ßÇö À¯µµ 3½Ã°£ Induction½ÃŲ °Í (Á¶±³µéÀÌ ¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   4page   1,000 ¿ø
Accessory overview ix35

Accessory overview ix35

Accessory overview ix35 / 3. Product details exterior protection Rear bumper loading protection 2S272ADE00 REAR BUMPER LOADING PROTECTOR BLACK Specifications Tailor made black bumper protec¡¦
»ç¾÷°èȹ > ±âŸ   38page   3,000 ¿ø
CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW

CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW

CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW / CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW CONTENTS 1. Clinical Trials 3. Phase 3 2. Phase 1 WH¡¦
·¹Æ÷Æ® > ±âŸ   9page   1,000 ¿ø
Introduction: An Overview of Microbiology and Cell Biology

Introduction: An Overview of Microbiology and Cell Biology

[·¹Æ÷Æ®]AnOverviewofMicrobiologyandCellBiology / 1. Microorganisms as Cells 2. Molecular Processes in Cells 3. Growth, Mutation, and Evolution 4. Cell Structure 6. Population, Communities, and Ecosystems 7. Laboratory Culture of Microorganisms 8. The Impact of Microorganisms on Human Affairs 9. A Brief History of Microbiology / 9. A Brief History of Micro¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   5page   1,000 ¿ø
Parkinson`s DiseaseÀÇ overview

Parkinson`s DiseaseÀÇ overview

Parkinson`s DiseaseÀÇ overview / pharm_322 / Symptoms pdÀÇ ÀϹÝÀûÀÎ Áõ»óÀ¸·Î´Â muscle stiffness(±ÙÀ°°æÁ÷), weakness, hypokinesia (¿îµ¿±â´É°¨¼ÒÁõ) bradykinesia (¿îµ¿¿Ï¸¸), Á¤Áö»óÅ¿¡¼­ÀÇ ¼Õ¶³¸², ¾öÁö ¹× ¶§·Î´Â Áý°Ô¼Õ°¡¶ôÀÇ Æ¯Â¡ÀûÀÎ `pill-rolling` motionµîÀÌ ÀÖ´Ù. pd ȯÀÚ´Â »óü¸¦ ¾ÕÀ¸·Î ±¸ºÎ¸®°í ÀÛ°í ÁúÁú ²ø¸é¼­ ÆÈÀ» ÈçµéÁö ¾ÊÀ¸¸ç °È´Â´Ù. ±ÕÇü¿¡µµ ¹®Á¦°¡ »ý¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   4page   1,000 ¿ø




ȸ»ç¼Ò°³ | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 ¤Ó ±¤ÁÖ±¤¿ª½Ã ±¤»ê±¸ ¹«Áø´ë·Î 326-6, 201È£ | äÈñÁØ | Åë½Å : ±¤»ê0561È£
Copyright¨Ï ¿Ã·¹¼ÒÇÁÆ® All rights reserved | Tel.070-8744-9518
ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ ¤Ó °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 | Tel.070-8744-9518